Babushok D, DeZern A, de Castro C, Rogers Z, Beenhouwer D, Broder M
Blood Adv. 2024; 8(15):3946-3960.
PMID: 38669341
PMC: 11331724.
DOI: 10.1182/bloodadvances.2023011642.
Sharma V, Namdeo M, Kumar P, Mitra D, Chattopadhyay P, Sazawal S
Iran Biomed J. 2023; 27(6):357-65.
PMID: 37980558
PMC: 10826914.
DOI: 10.61186/ibj.3754.
Bulduk T
Medicine (Baltimore). 2023; 102(36):e34862.
PMID: 37682205
PMC: 10489188.
DOI: 10.1097/MD.0000000000034862.
Lionel S, Selvarajan S, Korula A, Kulkarni U, Devasia A, Abubacker F
Indian J Hematol Blood Transfus. 2023; 39(3):419-428.
PMID: 37304482
PMC: 10247602.
DOI: 10.1007/s12288-022-01597-z.
Yu W, Wang Q, Ge M, Shi X
Clin Exp Med. 2022; 23(5):1815-1822.
PMID: 36244022
DOI: 10.1007/s10238-022-00909-x.
Cluster analysis of lymphocyte subset from peripheral blood in newly diagnosed idiopathic aplastic anaemia patients.
Yu W, Wang Q, Ge M, Shi X
Ann Med. 2022; 54(1):2431-2439.
PMID: 36066098
PMC: 9481148.
DOI: 10.1080/07853890.2022.2118367.
Relationship between immune status after ATG treatment and PNH clone evolution in patients with severe aplastic anemia.
Wang H, Liu H, Wang T, Li L, Liu C, Li L
J Clin Lab Anal. 2020; 35(3):e23667.
PMID: 33249661
PMC: 7958003.
DOI: 10.1002/jcla.23667.
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of....
Pulsipher M, Lehmann L, Bertuch A, Sasa G, Olson T, Nakano T
Pediatr Blood Cancer. 2020; 67(10):e28444.
PMID: 32776425
PMC: 9533334.
DOI: 10.1002/pbc.28444.
The Use of Natural Agents to Counteract Telomere Shortening: Effects of a Multi-Component Extract of Bunge and Danazol.
Guinobert I, Blondeau C, Colicchio B, Oudrhiri N, Dieterlen A, Jeandidier E
Biomedicines. 2020; 8(2).
PMID: 32059353
PMC: 7168059.
DOI: 10.3390/biomedicines8020031.
A cohort study of immune and hematopoietic functionality changes in severe aplastic anemia patients treated with immunosuppressive therapy.
Guan J, Sun Y, Fu R, Wang H, Ruan E, Wang X
Medicine (Baltimore). 2019; 98(3):e14149.
PMID: 30653151
PMC: 6370062.
DOI: 10.1097/MD.0000000000014149.
Short Telomere Syndromes in Clinical Practice: Bridging Bench and Bedside.
Mangaonkar A, Patnaik M
Mayo Clin Proc. 2018; 93(7):904-916.
PMID: 29804726
PMC: 6035054.
DOI: 10.1016/j.mayocp.2018.03.020.
Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia.
Xu L, Liu Z, Wu Y, Yang X, Cao Y, Li X
Eur J Med Res. 2018; 23(1):12.
PMID: 29490698
PMC: 5831581.
DOI: 10.1186/s40001-018-0311-3.
Androgen Therapy for Acute Myeloid and Hairy Cell Leukemia.
Wiernik P
Curr Treat Options Oncol. 2018; 19(1):4.
PMID: 29362898
DOI: 10.1007/s11864-018-0519-z.
Improved outcome of haploidentical transplantation in severe aplastic anemia using reduced-intensity fludarabine-based conditioning.
Yamei W, Rongmu L, Yongbin C, Yingjian S, Xiaohong L, Xiaomei Z
Oncotarget. 2017; 8(48):83817-83830.
PMID: 29137385
PMC: 5663557.
DOI: 10.18632/oncotarget.19745.
[Clinical characteristics of clonal evolution after immunosuppressive therapy in children with severe/very severe aplastic anemia].
Zhang J, Liu T, Chang L, Chen X, Ren Y, Sun C
Zhongguo Dang Dai Er Ke Za Zhi. 2017; 19(1):27-33.
PMID: 28100318
PMC: 7390118.
Danazol Treatment for Telomere Diseases.
Townsley D, Dumitriu B, Liu D, Biancotto A, Weinstein B, Chen C
N Engl J Med. 2016; 374(20):1922-31.
PMID: 27192671
PMC: 4968696.
DOI: 10.1056/NEJMoa1515319.
Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia.
Dietz A, Lucchini G, Samarasinghe S, Pulsipher M
Curr Opin Pediatr. 2015; 28(1):3-11.
PMID: 26626557
PMC: 4725196.
DOI: 10.1097/MOP.0000000000000299.
Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.
Narita A, Muramatsu H, Sekiya Y, Okuno Y, Sakaguchi H, Nishio N
Haematologica. 2015; 100(12):1546-52.
PMID: 26315930
PMC: 4666330.
DOI: 10.3324/haematol.2015.132530.
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.
Inamoto Y, Flowers M, Wang T, Urbano-Ispizua A, Hemmer M, Cutler C
Biol Blood Marrow Transplant. 2015; 21(10):1776-82.
PMID: 26033280
PMC: 4568149.
DOI: 10.1016/j.bbmt.2015.05.023.
Model-Based Determination of Effective Blood Concentrations of Cyclosporine for Neutrophil Response in the Treatment of Severe Aplastic Anemia in Children.
Philippe M, Henin E, Bertrand Y, Plantaz D, Goutelle S, Bleyzac N
AAPS J. 2015; 17(5):1157-67.
PMID: 25975616
PMC: 4540742.
DOI: 10.1208/s12248-015-9779-8.
